Skip to main content

How Senior Citizens from Cold Climates Deal with GI Biopsies in the Desert (An Emeritus Experience)



Original release date:
April 17, 2020
Access to this course expires on:  January 29, 2023 at 11:59 PM Pacific Time
CME 17.5

Course Description
Gastrointestinal pathology emerged as a subspecialty in the early 1980s, roughly coincident with development of endoscopy and mucosal biopsy for diagnosis and management of patients with gastrointestinal disorders. At that time, a number of pathologists dedicated their efforts to recognizing and classifying patterns of disease based on careful morphologic assessment, unassisted by immunohistochemical and molecular techniques. Many of their observations and conclusions have held true for several decades underscoring their validity. These individuals have tremendous knowledge to share with learners at all stages in their careers, many of whom have come to rely heavily on ancillary tests to establish diagnoses rather than morphologic assessment. Pathologists must be able to hone-in on key features in order to narrow the differential diagnosis and facilitate patient management. This special Emeritus course concentrates on the pioneers in gastrointestinal pathology and their prophetic perspectives.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Recognize and classify dysplasia in the setting of Barrett esophagus
  • Distinguish diagnostic features of medication and pathogen-related intestinal injury in the immunocompromised host
  • Formulate a differential diagnosis for sprue-like lesions of the small bowel
  • Distinguish invasive adenocarcinoma from mimics in biopsy material

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 17.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Beginning in 2021, the American Board of Pathology (ABPath) will no longer require Self-Assessment Modules (SAMs) for Part II Lifelong Learning of the Continuing Certification program. For additional information, visit the ABPath website.

Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Henry Appelman, Linda Ferrell, Audrey Lazenby, Frank Mitros, David Owen, Robert Riddell, Dale Snover

The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: Steven D. Billings, Rhonda Yantiss

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. View and print your certificate by clicking here .

Buy the entire How Senior Citizens from Cold Climates Deal with GI Biopsies in the Desert course and get a great discount!

Not A Member? Click Here